A US Senate Health Committee hearing on 4 November on the status of the US COVID-19 response began with a reminder that acting Food and Drug Administration commissioner Janet Woodcock has strong bipartisan support as head of the agency.
The senior Republican member of the committee, North Carolina’s Richard Burr, noted there are vacancies at both the FDA and the National Institutes of Health and warned that nominees will...